China State Council Lines Up Tasks In Five Key Healthcare Reforms
This article was originally published in PharmAsia News
Executive SummaryChina's General Office of the State Council recently released the tasks identified for five key healthcare reforms in 2009: speed up establishment of a basic medical care system; set up a national essential drug system; improve the grassroots medical care service system; promote uniformity in basic public healthcare; and push for reform pilots in public hospitals. According to the line-up of requirements, the national essential drug list is to be finalized by the end of November, with all drugs included in the drug catalog of the national basic medical insurance. Public hospital reform pilots will be conducted in about 100 hospitals of 12 prefecture cities identified from the Eastern, Central and Western regions of China. The State Council task force, which leads the deepening of the healthcare reform, will inspect the overall implementation by year end. (Click here for more - Chinese language)
You may also be interested in...
The $9.7bn acquisition hinges on the small interfering RNA inclisiran, but an ongoing cardiovascular outcomes trial, manufacturing hurdles, and reimbursement challenges provide subjects for concern.
US congressional leaders and medtech industry advocacy group AdvaMed are giving their full-throated endorsement to a US-Mexico-Canada (USMCA) trade agreement announced by the US Trade Representative's Office on 10 December. See what AdvaMed's president and CEO, Scott Whitaker, said about it in a statement here.
FDA seems poised to approve the drug for the orphan eye disease called TED, but remains concerned about labeling for some adverse events.